Compare Logitech International SA (LOGI) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs Sana Biotechnology Inc — how do they compare? Logitech International SA trades at $102.41 (market cap $14.96B), while Sana Biotechnology Inc trades at $3.77 (market cap $1.13B). The key difference: Logitech International SA is far larger — about 13.2× Sana Biotechnology Inc's market cap, and Logitech International SA pays a 1.64% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| LOGI | SANA | |
|---|---|---|
Market Cap | $14.96B | $1.13B |
Sector | Technology | Health |
52-Week High | $126.69 | $5.92 |
52-Week Low | $85.84 | $2.68 |
Enterprise Value | $13.30B | $1.05B |
Dividend Yield | 1.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Logitech (LOGI) trades at $101.92, down 2.81% amid technical bearish signals and supply chain concerns. The stock shows strong fundamentals with three consecutive quarterly earnings beats, robust 35.29% ROE, and 16.28% net margins. Recent Q1 2027 results exceeded expectations with $1.85 EPS versus $1.26 expected, though a semiconductor supplier shutdown creates near-term uncertainty.
Outlook remains mixed with 26% upside to consensus $109.75 target but tempered by supply risks. Investment case hinges on Logitech's premium product demand and margin expansion potential, balanced against Q3 2027 supply constraints and divided analyst sentiment (26% Buy, 47% Hold, 26% Sell).
SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
